(Q42469710)

English

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function

scientific article published on 2 April 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

1

object named as

Vedat Tiyerili

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

8

object named as

Georg Nickenig

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

9

object named as

Sven Wassmann

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Sebastian Zimmer

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Suzin Jung

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Kerstin Wassmann

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Claas P Naehle

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Dieter Lütjohann

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Andreas Zimmer

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

2 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Basic Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

465-477

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

https://api.crossref.org/works/10.1007%2FS00395-010-0090-7

21 January 2018

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1007%2FS00395-010-0090-7

21 January 2018

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1007%2FS00395-010-0090-7

21 January 2018

Identifiers

10.1007/S00395-010-0090-7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42469710&oldid=2205419723"